We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Attacking Cancer Cells With Viruses

News   May 28, 2020 | Original story from Hokkaido University

 
Attacking Cancer Cells With Viruses

The AdARET killed cancer cells (A549, H1299, and C33A) in a dose-dependent manner while normal cells (BJ and WI38) were largely unaffected particularly with small doses of AdARET. Living cells were stained blue. MOI indicates the number of virus particles per cell. (Yohei Mikawa et al., Cancers, May 11, 2020). Credit: Yohei Mikawa et al., Cancers, May 11, 2020

 
 
Advertisement
 

RELATED ARTICLES

“Common Cold” Coronaviruses Could Help Produce Anti-SARS-CoV-2 Immune Cells

News

Researchers examining immune cells produced against coronaviruses have uncovered a wealth of information about how this critical aspect of immunity could fight off COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. The new study provides hope that some immune responses to SARS-CoV-2 could be long-lasting.

READ MORE

How Much Fluorine Is Too Much?

News

A new study has explored whether soil fluorine levels in New Zealand are high enough to hurt a Rhizobium, bacteria that support legume crops.

READ MORE

Could Heparin Be Used To Stop SARS-CoV-2 From Infecting Human Cells?

News

SARS-CoV-2 uses a surface spike protein to latch onto human cells and initiate infection. But, the drug heparin is capable of binding tightly to the same surface spike protein, potentially blocking the infection from happening.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE